Iqvia Holdings earnings were $1.4B for the trailing 12 months ending Jun 30, 2026, with 16.5% growth year over year. The latest IQV earnings report on Jun 30, 2026 announced Q2 2026 earnings of $256.0M, down 6.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IQV reported annual earnings of $1.4B, with -0.9% growth.
IQV past earnings growth
How has IQV's earnings growth performed historically?
On IQV's earnings call on Jul 28, 2026, Iqvia Holdings (NYSE: IQV) reported Q2 2026 earnings per share (EPS) of $1.54, up 0.65% year over year. Total IQV earnings for the quarter were $256.00 million. In the same quarter last year, Iqvia Holdings's earnings per share (EPS) was $1.55.
As of the last Iqvia Holdings earnings report, Iqvia Holdings is currently profitable. Iqvia Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $1.38 billion, a 11.16% increase year over year.
What was IQV's earnings growth in the past year?
As of Iqvia Holdings's earnings date in Jul 28, 2026, Iqvia Holdings's earnings has grown 16.5% year over year. This is 5.29 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 11.21%. IQV earnings in the past year totalled $1.38 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.